AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Fluid-responsiveness Assessment Simplified by Electric Cardiometry in Children

Recruitingn/aAges 0 Days - 8 YearsAllUniversity Hospital, Bordeaux
💬

In plain words

What the trial is, and whether it could suit you

In this study of diagnostic accuracy, the investigators aim to validate a faster, simpler, and noninvasive test of fluid-responsiveness in critically ill children. This test is based on an assessment of the hemodynamic effects of a standardized abdominal compression, using electrical cardiometry. This would help physicians to identify more easily which patient could benefit from a volume expansion, thus avoiding a potentially useless or even dangerous fluid expansion that could lead to fluid overload. To this end, the diagnostic accuracy of electrical cardiometry-based stroke volume (SV) variation induced by a standardized abdominal compression to predict fluid responsiveness (define as a 15% increase in echocardiographically measured SV after volume expansion) will be measured.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age less than or equal to 8 years old * Hospitalization in a pediatric intensive care unit * Prescription by the attending physician of a fluid expansion of 10ml/kg * Use of a non-invasive cardiac output monitoring device (electrical cardiometry) as part of routine care Exclusion Criteria: * Patient less than 37 weeks' corrected gestational age * Hemodynamic instability making the delay necessary for any test dangerous * Supine position contraindicated or deleterious * Impairment of echocardiographic acoustic window or restless patient making ultrasonography impossible * Opposition to participate expressed by the patient or by a parent or legal guardian * Intra-abdominal hypertension, painful abdominal palpation or abdominal surgery in the last 15 days
💊

What it tests

  • validation a test of fluid-responsiveness in critically ill children
📍

Where

4 sites
Hôpital Marie Lannelongue
Le Plessis-Robinson, France
Hôpital Arnaud de Villeneuve - CHU de Montpellier
Montpellier, France
Hôpital mère-enfant - CHU de Nantes
Nantes, France
Hôpital Cardiologique Haut Lévêque - CHU de Bordeaux
Pessac, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy